The Securities and Exchange Board of India (SEBI) has ordered forensic audit of Venmax Drugs and Pharmaceuticals (VDPL), which figures in the list of suspected shell companies. The order is to check misuse of funds even as the regulator lifted trading curbs imposed on it. The regulator has directed the exchange to appoint an independent forensic auditor.
VDPL is among the firms against whom SEBI initiated action on August 7 by ordering trading restrictions after it received the list of 331 suspected shell companies from the government.
Venmax Drugs and Pharmaceuticals (formerly known as Yenkey Drugs and Pharmaceuticals) manufactures and sells pharmaceuticals and drugs in India. It trades in bulk drugs, intermediates, and biotech products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: